Related Interviews

Strong Fundamentals in Biotech Justify Even Higher Valuation Levels
December 11, 2014
Kantor, Jason

Biotech Space Concentrates on Gene Therapy, CAR T-Cell Technology Side
July 23, 2014
Nierengarten, David

A Large-Cap Growth Strategy Focused on Capital Appreciation and Income
January 28, 2014
Burnham, Jon M.

Increased Biotech Productivity and Innovation Reflected in FDA-Approved Drugs
August 23, 2013
Tenthoff, Ted

High Success Rates and Significant M&A in the Antibody Space
April 16, 2013
Kantor, Jason

U.S. Biotech Valuations Appear Attractive Despite Earlier Run
August 17, 2012
Birchenough, Jim

Nano Manufacturing Prospects In Semiconductors - Daniel Heyler - Bank Of America Merrill Lynch (asia Pacific) Ltd.
June 13, 2011
Heyler, Daniel

Health Care Services & Tech Outlook - Ross Muken - Deutsche Bank Securities, Inc.
November 15, 2010
Muken, Ross

INVESTING IN DIABETES-RELATED STOCKS - DAVID A. KLIFF - DIABETIC INVESTOR
November 17, 2008
Kliff, David A.

Roundtable Forum: Gaming
October 06, 2003
Greff, Joseph, Fath, Joseph

L.holtz / Y.lipsker - Roger Engemann & Associates
July 28, 2003
Lipsker, Yossi, Holtz, Lou

Ian Smith - Vertex Pharmaceuticals Inc (vrtx)
June 02, 2002
Smith, Ian F.

R.schwarzkopf / S.gleason - Kayne Anderson Rudnick Investment Mgmt Llc
February 25, 2002
Gleason, Sandi L., Schwarzkopf, Robert A.

R.crit Thomas - Armada Funds
February 04, 2002
Thomas, R. Crit

Medical Device Companies / Small & Mid-cap: Charles Olsziewski - Ubs Warburg
October 12, 2001
Olsziewski, Charles

Mark Frevert - Enron Wholesale Services (ene)
May 31, 2001
Frevert, Mark A.

Harry Penner Jr. - Neurogen Corporation (nrgn)
December 02, 1999
Penner, Harry

Pin It on Pinterest

Share This